Open AccessThe role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration
Author(s) -
Meira Neudorfer,
AudeliaEshel Fuhrer,
Dinah Zur,
Adiel Barak
Publication year - 2018
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_373_18
Subject(s) - medicine , posterior vitreous detachment , interquartile range , macular degeneration , ophthalmology , bevacizumab , pro re nata , visual acuity , prospective cohort study , vitrectomy , surgery , ranibizumab , chemotherapy
A prospective cohort study investigating the effect of posterior vitreous detachment (PVD) on the efficacy of intravitreal bevacizumab for exudative age-related macular degeneration (AMD), in view of evidence that the vitreoretinal interface impacts the severity of the disease.